Tuesday, November 24, 2009, 4:15am EST - Canadian Markets open in 5 hours and 15 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

SurModics Inc. (SRDX)

 On Nov 23: 23.17 USD   0.00 (0.00%)  
MORE ON SRDX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SurModics, Inc. (NasdaqNM:SRDX) Delayed quote dataEdit
Last Trade: 23.17 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 23.17
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 57.71
Day's Range: N/A - N/A
52wk Range: 15.96 - 31.00
Volume: 0
Avg Vol (3m): 144,985
Market Cap: 402.39M
P/E (ttm): 140.42
EPS (ttm): 0.17
Div & Yield: N/A (N/A%)
SurModics Inc. (SRDX)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add SRDX to Portfolio   Download Data

HEADLINES
• Piper Jaffray Senior Research Analyst Sees M&A Activity As Brisk As Foreign Companies Seek US Specialty Pharmaceutical Distribution Networks
Wall Street Transcript (Fri, Nov 13)
• How to Navigate the Raging Bull: Friday's PowerRatings 3 Pack
TradingMarkets.com (Fri, Nov 6)
• SurModics Misses
Zacks.com (Thu, Nov 5)
• New Star Analyst Rankings for SurModics, Inc.
StarMine (Thu, Nov 5)
• SurModics, Inc.Q4 2009 Earnings Call Transcript
at Seeking Alpha (Wed, Nov 4)
• SurModics, Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Wed, Nov 4)
• SURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
• SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
Business Wire (Wed, Nov 4)
• Q4 2009 SurModics, Inc. Earnings Release - After Market Close
CCBN (Wed, Nov 4)
• SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment
Business Wire (Mon, Nov 2)
• SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4
Business Wire (Wed, Oct 28)
More Headlines for SRDX...
ANALYST
EPS Est (next year) (Sep-08) : N/A
EPS Est (in 2 years) (Sep-09) : N/A
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
SurModics, Inc. engages in the development, manufacture, and sale of surface modification and drug delivery technologies to the healthcare industry. The company operates in three segments: Drug Delivery, Hydrophilic and Other, and In Vitro.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices